electroCore (ECOR) Stock Price, News & Analysis

Company Overview

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Key Stats

• Today's Range: $9.60 to $10.45
• 50-Day Range: $5.85 to $13.60
• 52-Week Range: $5.02 to $14.20
• Volume: 83,097 shs
• Average Volume: 28,357 shs
• Market Capitalization: $65.11 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

electroCore Stock Analysis - MarketRank™

electroCore scored higher than 16% of companies evaluated by MarketBeat, and ranked 900th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for electroCore.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for electroCore are expected to grow in the coming year, from ($1.44) to ($0.37) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of electroCore is -5.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of electroCore is -5.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

electroCore has a P/B Ratio of 8.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.83% of the float of electroCore has been sold short.

Short Interest Ratio / Days to Cover

electroCore has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in electroCore has recently increased by 64.12%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

electroCore does not currently pay a dividend.

Dividend Growth

electroCore does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.83% of the float of electroCore has been sold short.

Short Interest Ratio / Days to Cover

electroCore has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in electroCore has recently increased by 64.12%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.13

News Sentiment

electroCore has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 16 news articles for electroCore this week, compared to 1 article on an average week.

Search Interest

2 people have searched for ECOR on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added electroCore to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, electroCore insiders have not sold or bought any company stock.

Percentage Held by Insiders

19.70% of the stock of electroCore is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 26.74% of the stock of electroCore is held by institutions.

ECOR Stock Analysis - Frequently Asked Questions

How have ECOR shares performed this year?

electroCore's stock was trading at $5.95 at the beginning of the year. Since then, ECOR stock has increased by 67.1% and is now trading at $9.94.
View the best growth stocks for 2024 here.

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) announced its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.39) by $0.01. The company had revenue of $6.14 million for the quarter, compared to the consensus estimate of $5.85 million. electroCore had a negative trailing twelve-month return on equity of 154.45% and a negative net margin of 54.40%.

When did electroCore's stock split?

Shares of electroCore reverse split before market open on Tuesday, February 14th 2023. The 1-15 reverse split was announced on Tuesday, February 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did electroCore IPO?

electroCore (ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.

Who are electroCore's major shareholders?

Top institutional shareholders of electroCore include International Assets Investment Management LLC (8.91%), Geode Capital Management LLC (0.98%) and HighTower Advisors LLC (0.55%). Insiders that own company stock include Daniel S Goldberger, Thomas J Errico, Joseph P Errico, John P Gandolfo, Trevor J Moody and Brian M Posner.
View institutional ownership trends.

How do I buy shares of electroCore?

Shares of ECOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some other companies that electroCore investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Tesla (TSLA), CymaBay Therapeutics (CBAY) and General Electric (GE).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:ECOR
• CUSIP: N/A
• CIK: 1560258
• Web: www.electrocore.com
• Phone: (973) 290-0097
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.83)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-18,830,000.00
• Net Margins: -54.40%
• Pretax Margin: -54.82%
• Return on Equity: -154.45%
• Return on Assets: -69.16%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.12
• Quick Ratio: 1.87

Sales & Book Value

• Annual Sales: $16.03 million
• Price / Sales: 4.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.24 per share
• Price / Book: 8.02

Miscellaneous

• Outstanding Shares: 6,550,000
• Free Float: 5,264,000
• Market Cap: $65.11 million
• Optionable: Not Optionable
• Beta: 0.56